Olatoyosi Odenike
0000-0002-4027-4124
Publication & Citation Trends
Publications
354 total
Low Serum Cholesterol Is a Biomarker of Advanced Disease and Poor Outcomes in Myeloproliferative Neoplasms.
Cited by 0
Semantic Scholar
Echocardiographic high-output heart failure is associated with worse survival among patients with myelofibrosis.
Cited by 0
Semantic Scholar
Hematologic complications in patients exposed to poly-ADP ribose polymerase inhibitors.
Cited by 0
Semantic Scholar
Ruxolitinib and heart failure outcomes among patients with myelofibrosis.
Cited by 0
Semantic Scholar
Clinical Outcomes of Older Patients with NPM1-Mutated or KMT2A-Rearranged AML Before Menin Inhibitors: A Beat AML Report.
Cited by 0
Semantic Scholar
Targeting menin in T-lineage acute lymphoblastic leukemia.
Cited by 0
Semantic Scholar
Trial in progress – a phase 1b trial of ivosidenib combined with ruxolitinib in IDH1-mutated advanced myeloproliferative neoplasms
Cited by 0
Semantic Scholar
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML
Cited by 25
Semantic Scholar
Research Topics
Acute Myeloid Leukemia Research
(214)
Chronic Myeloid Leukemia Treatments
(108)
Acute Lymphoblastic Leukemia research
(98)
Myeloproliferative Neoplasms: Diagnosis and Treatment
(98)
Chronic Lymphocytic Leukemia Research
(50)
Affiliations
Loyola University Medical Center
American Society of Clinical Oncology
Chicago Department of Public Health
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Weatherford College